# Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis

> **NCT05974579** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Université de Sherbrooke** · enrollment: 12 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** 89Zr-DFO-AP-101

## Key facts

- **NCT ID:** NCT05974579
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-23
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-03-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974579, "Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05974579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*